✦ New CED Clinical Relevance #50 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyIndustry Why This Matters I don't see a summary provided for this article. Without the...
France Cannabis Pilot Extended to 2027 | Medical Access Delayed | Hanf Magazin
✦ New CED Clinical Relevance #66Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyInternationalAccessRegulatory FrameworkImplementation Why This Matters France’s extension of their medical cannabis pilot program to...
Our Opinion: PA needs to get on board with legalized recreational marijuana
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyMedical CannabisPatient AccessRegulatory FrameworkClinical Guidance Why This Matters Pennsylvania’s potential recreational cannabis legalization would...
Downturn in medicinal cannabis prescriptions – RACGP
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Access BarriersHealthcare PolicyPrescribing PatternsRegulatory FrameworkPatient Access Why This MattersA documented decline in medicinal cannabis...
Sentencing Set May 6 for Two Former Rohnert Park Officers in Humboldt Cannabis Theft Case
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Legal IssuesPatient TrustMedical Cannabis ProgramsLaw EnforcementRegulatory Framework Why This MattersLaw enforcement misconduct in cannabis...
New Zealand: Nascent medical cannabis industry aims for growth
✦ New CED Clinical Relevance #76Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic International PolicyMarket AccessHealthcare IntegrationPharmaceutical StandardsRegulatory Framework Why This MattersMarket development in smaller healthcare systems...
Australia’s Medical Cannabis Regulation at Eight Years: Rapid Growth, Persistent Gaps
The number of prescriptions jumped from 231 in 2017 to more than one million by early 2024, generating an estimated market value of AUD $445.6 million. Yet notable barriers remain, including monthly costs that average between $200 and $600, uneven availability in remote areas, and variable knowledge levels among general practitioners and specialists.
Five years after Alabama legalized medical cannabis, first dispensary nears opening
✦ New CED Clinical Relevance #84High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic Medical AccessState PolicyRegulatory FrameworkPatient AccessClinical Implementation Why This MattersAlabama's first medical cannabis dispensary...
Number of Hampshire residents prescribed medical cannabis passes 3000
✦ New CED Clinical Relevance #76Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Medical AccessUk PolicyPrescription DataRegulatory FrameworkClinical Adoption Why This MattersRegional prescription data provides insight into...
India is ‘treasure trove’ of cannabis genetics, but policy will determine development
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic GeneticsPolicyResearchInternationalCultivation Why This MattersIndia's vast cannabis genetic diversity represents untapped potential for developing new...